Tosk is a biopharmaceutical company specializing in cancer treatments. It develops the Side Effect Fly technology using drosophila as a model to screen compounds for their potential to prevent the adverse effects of existing cancer therapies. The company also offers the Genetically Modified Fly used to insert human genes into drosophila for use in drug screening.
|Employees (est.) (Mar 2020)||14||(+17%)|
Tosk total Funding
Tosk latest funding size
Time since last funding
|6 years ago|
When was Tosk founded?
Tosk was founded in 1998.
Who are Tosk key executives?
Tosk's key executives are Brian D. Frenzel, Harold Crow and Charles Garvin.
How many employees does Tosk have?
Tosk has 14 employees.
Who are Tosk competitors?
Competitors of Tosk include Northwest Biotherapeutics, Merrimack Pharmaceuticals and Calithera Biosciences.
Receive alerts for 300+ data fields across thousands of companies